NCT07473128 2026-03-16
Effect of Trilaciclib in the Prevention of Myelosupression in Subjects With Limited-stage Small Cell Lung Cancer
Pharmacosmos A/S
Phase 3 Not yet recruiting
Clinical Trials
12 trialsNCT06079671 2026-02-27
eVOLVECervical
AstraZeneca
Phase 3 Recruiting
NCT03284866 2026-01-28
COVENANT
AIDS Malignancy Consortium
Phase 3 Completed
NCT04655144 2026-01-07
Dex-Fib
University of Miami
Phase 3 Completed
NCT06807437 2025-12-05
Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic Fistula
SWOG Cancer Research Network
Phase 3 Recruiting
NCT04874038 2025-11-17
Prevention of Persistent Pain With LidocAine iNfusions in Breast Cancer Surgery (PLAN)
University Health Network, Toronto
Phase 3 Recruiting
NCT04327063 2025-09-19
MIRs 04
Institut Curie
Phase 3 Completed
NCT07149506 2025-09-08
OCTOPUS-RD
Universidad de Guanajuato
Phase 3 Enrolling by invitation
NCT03351348 2025-08-26
Bupivacaine vs Placebo for Unilateral Mastectomy Surgical Site Post-operative Pain Control
Memorial Sloan Kettering Cancer Center
Phase 3 Recruiting
NCT04624204 2025-07-02
MK 7339-013
Merck Sharp & Dohme LLC
Phase 3 Active not recruiting
NCT05054543 2025-06-27
Study to Evaluate the Efficacy of Uproleselan in Combination With Chemotherapy in Chinese Patients With R/R AML
Apollomics Inc.
Phase 3 Terminated
NCT04199689 2025-03-25
V503-049
Merck Sharp & Dohme LLC
Phase 3 Active not recruiting